We're building a better ClinicalTrials.gov. Check it out and tell us what you think!
ClinicalTrials.gov Menu

Use of the Atkins Diet for Children With Sturge Weber Syndrome

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT00639730
Recruitment Status : Completed
First Posted : March 20, 2008
Last Update Posted : May 27, 2010
Vascular Birthmarks Foundation
Information provided by:
Johns Hopkins University

Brief Summary:

This research is being done to find out if the Atkins Diet can be used safely and effectively to reduce seizures in children who have Sturge Weber syndrome.

The ketogenic diet is a proven therapy for epilepsy, but can be difficult to use in children. The Atkins Diet is a high fat, high protein, low carbohydrate diet introduced in the 1970s to help with weight loss. It is different from the ketogenic diet in four major ways: no calorie restriction, no fluid restriction, no protein restriction, and is easy to start outside the hospital. People on the Atkins Diet become ketotic (produce high levels of ketones, a certain substance in the body), like patients on the ketogenic diet, and the investigators believe this may lead to seizure control.

Children aged 2-18 with Sturge Weber syndrome and seizures at least monthly, who have used at least two anti-seizure drugs may join. 5 children in total will be enrolled.

Condition or disease Intervention/treatment Phase
Epilepsy Sturge Weber Syndrome Dietary Supplement: modified Atkins diet Phase 1

Detailed Description:

If you agree to be in this study, we will ask you to do the following things:

Before the diet is started:

  • We will ask you to keep track of your child's seizures daily for 2 weeks before starting the Atkins diet and provide us with a 3-day food record as well.
  • Baseline blood (about 2 teaspoons) and urine work will be obtained.
  • We will give you a free copy of a carbohydrate-counting guide.
  • You will be asked to fill out a 3-day food record.

On the diet:

  • Give your child a daily calcium supplement and multivitamin.
  • Keep a daily seizure log.
  • Check urine for ketones (to make sure the diet is working) and specific gravity (to make sure your child is well hydrated) twice a week and when you come to clinic.
  • We will ask you to weigh your child at home every week, and we will weigh him or her when you come into clinic too.
  • Do not fluid restrict your child; please give plenty of carbohydrate-free fluids.
  • You will give 20 grams per day of carbohydrates. We will give you instructions on how to measure daily intake of carbohydrates.
  • We will not change medications for the first three months. Do not change your child's seizure medicines without checking with our doctors.
  • For the first three months, we ask you to avoid store-bought low-carbohydrate products (as they can have more carbohydrates than advertised).

After being on the diet for one month, Dr. Kossoff will contact you by telephone to discuss how your child is doing. You can also speak with one of our dietitians. We will discuss the 3-day food record with you

You will be asked to come to the clinic (outpatient center, 5th floor) for two follow-up visits:

  1. after being on the diet for 3 months and
  2. after being on the diet for 6 months.

During these visits you will meet with one of our doctors and a dietitian. We will review your child's seizure control and health. We may obtain blood (about 2 teaspoons). We will check your child's urine for ketones and specific gravity.

If the diet is helping beyond 6 months, we will help your child continue on the diet with clinic visits and labs as necessary, at a carbohydrate amount that is most helpful.

Layout table for study information
Study Type : Interventional  (Clinical Trial)
Estimated Enrollment : 5 participants
Allocation: Non-Randomized
Intervention Model: Single Group Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: Use of the Atkins Diet for Children With Sturge Weber Syndrome
Study Start Date : May 2006
Actual Primary Completion Date : March 2010
Actual Study Completion Date : May 2010

Arm Intervention/treatment
Experimental: A
This is open-label - all patients are placed on the diet. There is no control or placebo arm.
Dietary Supplement: modified Atkins diet
High fat, low carbohydrate diet

Primary Outcome Measures :
  1. Seizures [ Time Frame: 6 months ]
    Seizure frequency will be compared to baseline (pre-Diet).

Secondary Outcome Measures :
  1. Ketosis [ Time Frame: 6 months ]
  2. Safety (stroke like events) [ Time Frame: 6 months ]

Information from the National Library of Medicine

Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.

Layout table for eligibility information
Ages Eligible for Study:   2 Years to 18 Years   (Child, Adult)
Sexes Eligible for Study:   All
Accepts Healthy Volunteers:   No

Inclusion Criteria:

  • 2-18 years
  • Sturge Weber syndrome
  • Monthly seizures (at least)
  • Tried at least two anticonvulsants

Exclusion Criteria:

  • Prior use of the Atkins or ketogenic diets
  • Patients with non-epileptic seizures (pseudoseizures) will be excluded
  • Patients that are pregnant or become pregnant during the study will be excluded
  • High cholesterol

Information from the National Library of Medicine

To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.

Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT00639730

Layout table for location information
United States, Maryland
Johns Hopkins Hospital
Baltimore, Maryland, United States, 21287
Sponsors and Collaborators
Johns Hopkins University
Vascular Birthmarks Foundation
Layout table for investigator information
Principal Investigator: Eric H Kossoff, MD Johns Hopkins School of Medicine
Layout table for additonal information
Responsible Party: Eric Kossoff MD, Johns Hopkins School of Medicine
ClinicalTrials.gov Identifier: NCT00639730    
Other Study ID Numbers: NA_00003359
First Posted: March 20, 2008    Key Record Dates
Last Update Posted: May 27, 2010
Last Verified: May 2010
Keywords provided by Johns Hopkins University:
Additional relevant MeSH terms:
Layout table for MeSH terms
Sturge-Weber Syndrome
Brain Stem Infarctions
Klippel-Trenaunay-Weber Syndrome
Pathologic Processes
Brain Diseases
Central Nervous System Diseases
Nervous System Diseases
Brain Infarction
Brain Ischemia
Cerebrovascular Disorders
Vascular Diseases
Cardiovascular Diseases
Neoplasms, Vascular Tissue
Neoplasms by Histologic Type
Neurocutaneous Syndromes